THER
THERALINK TECHNOLOGIES, INC.Company Information
- Company Name
- THERALINK TECHNOLOGIES, INC.
- CIK
- CIK0001362703
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- THER: OTC
- Fiscal Year End
- September 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- THER
SEC filing data through
Insider Sentiment
- Last purchase
- 2015-05-18
- Last sale
- 2015-09-02
- Shares purchased (TTM)
- 71,396,544
- Shares sold (TTM)
- 54,548,272
Institutional Sentiment
- As of
- 2022-06-30
- Institutional shares owned
- 67
- Shares outstanding
- 6,062,411,449
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2024-02-20
- Price on filing date
- —
- 1-month reaction
- -18.18%
- 3-month reaction
- -45.45%
Balance Sheet
Values in millions ($)| Line item | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||||
| Cash | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | ||||||
| Accounts And Other Receivables Net Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Marketable Securities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Assets Noncurrent | |||||||||||||||||||
| Inventory Raw Materials And Supplies | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | ||||||
| Deferred Costs Current | - | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Deferred Costs | - | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||||
| Accounts Payable Current | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Payable Related Parties Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Accrued Liabilities Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Compensation Liability Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Employee Related Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Convertible Debt Current | - | - | - | 3 | 1 | - | - | - | - | - | 0 | - | - | ||||||
| Notes Payable Related Parties Classified Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Notes Payable Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Insurance Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Derivative Liabilities Current | 29 | 16 | 33 | 45 | 42 | - | - | - | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | ||||||
| Liabilities Current | 58 | 40 | 48 | 53 | 46 | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 1 | ||||||
Liabilities Noncurrent | |||||||||||||||||||
| Other Liabilities Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 59 | 41 | 49 | 55 | 48 | 6 | 5 | 4 | 5 | 4 | 3 | 3 | 2 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | - | 2 | 2 | 2 | ||||||
Stockholders Equity | |||||||||||||||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Debt Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Additional Paid In Capital | 55 | 55 | 55 | 55 | 54 | 55 | 49 | 49 | 46 | 44 | 43 | 42 | 42 | ||||||
| Retained Earnings Accumulated Deficit | -113 | -94 | -103 | -108 | -99 | -63 | -55 | -53 | -51 | -50 | -47 | -46 | -45 | ||||||
| Stockholders Equity | -57 | -38 | -47 | -52 | -44 | -7 | -5 | -4 | -5 | -5 | -3 | -3 | -2 | ||||||
| Liabilities And Stockholders Equity | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Accounts Receivable Related Parties Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 12,000 | 12,000 | - | 100,000 | 12,000 | 12,000 | 12,000 | ||||||
| Common Stock Shares Issued | 6,151 | 6,151 | 6,151 | 6,151 | 6,151 | 6,151 | 6,151 | 6,026 | 5,124 | 5,124 | 5,124 | 5,124 | 5,124 | ||||||
| Shares Outstanding | 6,151 | 6,151 | 6,151 | 6,151 | 6,151 | 6,151 | 6,151 | 6,026 | 5,124 | 5,124 | 5,124 | 5,124 | 5,124 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | 0 | - | - | - | 0 | - | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTHERALINK TECHNOLOGIES, INC. (THER) — SEC Financial Statements & Analysis
THERALINK TECHNOLOGIES, INC. (THER) is a pharmaceutical preparations company, incorporated in NV. THERALINK TECHNOLOGIES, INC. trades on OTC as: THER. THERALINK TECHNOLOGIES, INC. (THER)'s most recent SEC filing is a Form 10-Q for the period ended 2023-12-31, filed with the SEC on 2024-02-20. Based on that filing, THERALINK TECHNOLOGIES, INC. carries a market cap of $9.23M, a P/E ratio of -0.23x, a P/B ratio of -0.16x, a P/S ratio of 11.88x, an enterprise value of $9.23M, and an EV/EBITDA multiple of -0.85x. On profitability, it posts a gross margin of 80.47%, an operating margin of -1432.64%, a net margin of -5088.10%, a Return on Equity (ROE) of 77.92%, and a Return on Assets (ROA) of -1570.22%. Per share, it reports EPS of $-0.01, diluted EPS of $-0.01, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 32.21% year-over-year, net income growth of 171.05% year-over-year, and EPS growth of 171.05% year-over-year. On the balance sheet, it maintains a current ratio of 0.00x, a quick ratio of 0.00x, working capital of $-57.53M, a debt-to-equity ratio of -1.03x, a debt ratio of 33.01, an interest coverage ratio of -0.51x, free cash flow of $-8.49M (TTM), and net debt of $-301. Figures sourced from SEC EDGAR.
- Market Cap
- $9.23M
- P/E TTM
- -0.23x
- EPS TTM
- $-0.01
- P/B TTM
- -0.16x
- ROE TTM
- 77.92%
- ROA TTM
- -1570.22%
- Debt To Equity
- -1.03x
- Free Cash Flow TTM
- $-8.49M
- Net Revenue TTM Growth 1Y
- 32.21%
Data as of 2023-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is THERALINK TECHNOLOGIES, INC. in?
THERALINK TECHNOLOGIES, INC. (THER) operates in the Pharmaceutical Preparations industry.
What exchange does THER trade on?
THERALINK TECHNOLOGIES, INC. (THER) trades on the OTC.
Where is THERALINK TECHNOLOGIES, INC. incorporated?
THERALINK TECHNOLOGIES, INC. is incorporated in NV.
When was THERALINK TECHNOLOGIES, INC. (THER)'s most recent SEC filing?
THERALINK TECHNOLOGIES, INC. (THER)'s most recent SEC filing is a Form 10-Q for the period ended 2023-12-31, filed with the SEC on 2024-02-20.
What is THER's market cap?
THERALINK TECHNOLOGIES, INC. (THER) has a market capitalization of $9.23M as of 2023-12-31.
What is THER's EPS (earnings per share)?
THERALINK TECHNOLOGIES, INC. (THER)'s trailing twelve month EPS is $-0.01 as of 2023-12-31.
What is THER's ROE (return on equity)?
THERALINK TECHNOLOGIES, INC. (THER)'s trailing twelve month Return on Equity (ROE) is 77.92% as of 2023-12-31.
What is THER's ROA (return on assets)?
THERALINK TECHNOLOGIES, INC. (THER)'s trailing twelve month Return on Assets (ROA) is -1570.22% as of 2023-12-31.
What is THER's EV/EBITDA?
THERALINK TECHNOLOGIES, INC. (THER)'s trailing twelve month EV/EBITDA is -0.85x as of 2023-12-31.